Biden promotes US biotech, cancer fight in new 'Moonshot'

Biden promotes US biotech, cancer fight in new 'Moonshot'

President Joe Biden is calling for a national effort against cancer to match NASA's Moon mission
President Joe Biden is calling for a national effort against cancer to match NASA's Moon mission. Photo: Mandel NGAN / AFP
Source: AFP

President Joe Biden issued an executive order Monday boosting the US biotech sector as part of his Cancer Moonshot initiative, which invokes the national effort to land a man on the Moon 60 years ago.

The Democrat was in Boston for an address deliberately set to echo John F. Kennedy's famous 1962 "Moonshot speech" in which he called for landing an American on the lunar surface -- something achieved in 1969.

This time, Biden is pushing for government-backed efforts to coordinate and fund a multilayered fight against cancer, with the goal of halving cancer death rates in the next 25 years.

As he set off from Washington, Biden issued an order meant to bolster the trailblazing US biotech sector's efforts to take on growing commercial rivals in China.

Read also

After pulling out of TPP, US forges Asia trade framework

The order brings federal support for "areas that will define US biotechnology leadership and our economic competitiveness in the coming decades," a senior Biden administration official told reporters.

The official said that while US biotech research leads the world, the industrial applications are increasingly in the hands of other countries.

PAY ATTENTION: Share your outstanding story with our editors! Please reach us through info@corp.legit.ng!

"Unless we translate biotechnology innovation into economic and societal benefits for all Americans, other countries, including and especially China, are aggressively investing in this sector," posing a "risk," the official said.

The White House says the US biotech industry is on the cutting edge of medical advances -- recently seen in the rapid development of vaccines, tests and therapeutics to help manage the Covid-19 pandemic -- but that the potential scope goes much further.

The official speaking to reporters cited studies suggesting that "before the end of the decade, engineering biology holds the potential to be used in manufacturing industry that accounts for more than one third of global output. That's equivalent to almost $30 trillion in terms of value."

Read also

Egypt vows to champion climate finance for Africa at COP27

Growing areas for biotech industry include new plastics and rubbers, jet fuel, and environmentally friendly fertilizers.

Personal issue for Biden

The battle against cancer is personal for Biden: his son Beau died of brain cancer in 2015 when Biden was vice president to Barack Obama.

In his speech at the John F. Kennedy Library and Museum in Boston, Biden will lay out how his administration is seeking to slash cancer rates through a systemic revamp of government funding and support for everything from medical research to improving access to healthcare and better environmental conditions.

The linkage to the Moon program will seek to raise public awareness and support ahead of midterm congressional elections where the Democrats face the possibility of a Republican sweep in Congress, something which would severely complicate the next two years of Biden's first term.

Caroline Kennedy, the US ambassador to Australia and daughter of the assassinated JFK, told CNN she approved of the parallels drawn by Biden in the struggle to conquer the deadly disease.

Read also

Stocks tank, dollar rises as traders prepare for big rate hikes

"Sixty years after my father challenged Americans to land on the moon, President Biden is welcoming great challenges as new opportunities by setting us on a bold course to end cancer as we know it," she said.

Biden's focus on the cancer fight comes as NASA is once again looking to return to the Moon.

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.